Atrial fibrillation in hypertrophic cardiomyopathy-A contemporary mini-review

被引：10

作者：

Dragasis, Stylianos ^{[1
]}

Vlachos, Konstantinos ^{[1
]}

Kariki, Ourania ^{[1
]}

Koskina, Stavroula ^{[1
]}

Zygouri, Andromahi ^{[1
]}

Patsiotis, Ilias G. ^{[2
]}

Anastasakis, Aris ^{[1
]}

Athanasopoulos, George ^{[1
]}

Ritsatos, Konstantinos ^{[1
]}

Letsas, Konstantinos ^{[1
]}

Efremidis, Michael ^{[1
]}

机构：

[1] Onassis Cardiac Surg Canter, Leof Andrea Siggrou 356, Athens 17674, Greece

[2] Gen State Hosp Nikaia St Panteleimon, Nikaia, Greece

来源：

HELLENIC JOURNAL OF CARDIOLOGY | 2022年 / 67卷

关键词：

Atrial fibrillation; Hypertrophic cardiomyopathy; Arterial thromboembolism; CLINICAL PROFILE; SURGICAL ABLATION; OUTCOMES; IMPACT; PREDICTORS; MANAGEMENT; DIAGNOSIS; FIBROSIS; CATHETER; STROKE;

D O I：

10.1016/j.hjc.2022.05.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hypertrophic cardiomyopathy (HCM) represents the most common genetically inherited cardiovascular disorder and a leading cause of heart failure and sudden cardiac death. Atrial fibrillation (AF) is the most common arrhythmia encountered in HCM patients, primarily due to the process of left atrium dilatation and remodeling. Its presence typically leads to progressive functional decline, increased frequency of heart failure hospitalizations, and increased thromboembolic risk. In this mini-review, we summarize the contemporary data on AF pathophysiology, risk factors, and management in HCM patients suffering from AF.(c) 2022 Hellenic Society of Cardiology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

引用

页码：66 / 72

页数：7

共 50 条

[1] Progress in the Molecular Genetics of Hypertrophic Cardiomyopathy: A Mini-Review
Tian, Tao
Liu, Yaxin
Zhou, Xianliang
Song, Lei
GERONTOLOGY, 2013, 59 (03) : 199 - 205
[2] Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Rowin, Ethan J.
Link, Mark. S.
Maron, Martin S.
Maron, Barry J.
CIRCULATION, 2023, 148 (22) : 1797 - 1811
[3] Atrial Fibrillation in Hypertrophic Cardiomyopathy
El-Battrawy, Ibrahim
Borggrefe, Martin
Akin, Ibrahim
JACC-HEART FAILURE, 2018, 6 (09) : 807 - 807
[4] Atrial Fibrillation in Hypertrophic Cardiomyopathy
Vaidya, Kaivan
Semsarian, Christopher
Chan, Kim H.
HEART LUNG AND CIRCULATION, 2017, 26 (09): : 975 - 982
[5] Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review
Patricia Alphonse
Sohaib Virk
Jhonna Collins
Timothy Campbell
Stuart P. Thomas
Christopher Semsarian
Saurabh Kumar
Clinical Research in Cardiology, 2021, 110 : 544 - 554
[6] Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review
Guttmann, Oliver P.
Rahman, M. Shafiqur
O'Mahony, Constantinos
Anastasakis, Aris
Elliottl, Perry M.
HEART, 2014, 100 (06) : 465 - 472
[7] Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review
Alphonse, Patricia
Virk, Sohaib
Collins, Jhonna
Campbell, Timothy
Thomas, Stuart P.
Semsarian, Christopher
Kumar, Saurabh
CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (04) : 544 - 554
[8] Systematic review of atrial fibrillation and stroke in patients with hypertrophic cardiomyopathy
Guttmann, O. P.
Rahman, S.
O'Mahony, C.
Anastasakis, A.
Elliott, P.
EUROPEAN HEART JOURNAL, 2013, 34 : 530 - 530
[9] Atrial fibrillation in patients with hypertrophic cardiomyopathy
Puchnerova, Veronika
Jensovsky, Michael
Ostadal, Petr
Bonaventura, Jiri
COR ET VASA, 2024, 66 (04) : 429 - 434
[10] Predictors of atrial fibrillation in hypertrophic cardiomyopathy
Guttmann, Oliver P.
Pavlou, Menelaos
O'Mahony, Constantinos
Monserrat, Lorenzo
Anastasakis, Aristides
Rapezzi, Claudio
Biagini, Elena
Gimeno, Juan Ramon
Limongelli, Giuseppe
Garcia-Pavia, Pablo
McKenna, William J.
Omar, Rumana Z.
Elliott, Perry M.
HEART, 2017, 103 (09) : 672 - 678

← 1 2 3 4 5 →